Chemocentryx reported $4.95M in Trade Debtors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Alnylam Pharmaceuticals ALNY:US $ 142.27M 14.26M
Amgen AMGN:US $ 5327M 250M
AstraZeneca AZN:LN 9.61B 562M
Bayer BAYN:GR 18.39B 561M
Biogen BIIB:US $ 2003.5M 17.9M
Biomarin Pharmaceutical BMRN:US $ 466.51M 36.36M
Bristol Myers Squibb BMY:US $ 12540M 4029M
Chemocentryx CCXI:US $ 4.95M 2.14M
GlaxoSmithKline GSK:LN 6.87B 1.93B
Glaxosmithkline GSK:US $ 6870M 1927M
Macrogenics MGNX:US $ 18.38M 3.48M
Mirati Therapeutics MRTX:US $ 1.53M 0.28M
Novartis NOVN:VX 8.91B 232M
Sarepta Therapeutics SRPT:US $ 230.28M 33.07M
Takeda 4502:JP Y 794092M 69715M
Teva Pharmaceutical TEVA:IT 4.47B 218M
YTE INCY:US $ 682.97M 120.62M